Siemens Healthcare

Siemens Healthcare (Booth 922) is showcasing its post-processing solutions as well as the integration of CAD into advanced 3D applications and PACS. Siemens also is highlighting syngo Lung CAD, syngo CXR CAD and syngo MammoCAD.

syngo Lung CAD is CAD software for automated detection of solid pulmonary nodules in thoracic CT studies. It is available on the syngo MultiModality Workplace for use with syngo CT Oncology. Additionally, to enable the CAD results to be displayed on PACS workstations, syngo Lung CAD is integrated in the reading workflow of syngo Imaging and syngo Imaging XS.

syngo CXR CAD, which is not yet FDA-approved for sale in the U.S., is a second reader product for the detection of lung nodules in digital chest x-ray studies. syngo CXR CAD processes images of the posterior-anterior view and is optimized for the detection of lung nodules from 8mm to 30mm in size. syngo CXR CAD is validated for use with images from the Siemens AXIOM Aristos digital x-ray system, and the results can be displayed on PACS workstations.

syngo MammoCAD, which is not yet FDA-approved for sale in the U.S.,  is a CAD solution for full-field digital mammography and generates CAD marks to highlight suspicious areas, such as masses and microcalcifications. With syngo MammoCAD up to 40 percent of normal cases show no false positive CAD marks, saving the radiologist interpretation time during the second read phase.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.